Rivaroxaban versus Dalteparin in Cancer-Associated Thromboembolism: A Randomized Trial. Planquette B, Bertoletti L, Charles-Nelson A, Laporte S, et al. Chest 2021 Oct 7. pii: S0012-3692(21)04079-4. doi: 10.1016/j.chest.2021.

Read + Share

Amedeo Smart

Independent Medical Education

Planquette B, Bertoletti L, Charles-Nelson A, Laporte S, et al. Rivaroxaban versus Dalteparin in Cancer-Associated Thromboembolism: A Randomized Trial. Chest 2021 Oct 7. pii: S0012-3692(21)04079-4. doi: 10.1016/j.chest.2021.
PMID: 34627853